Summary
In the Linux kernel, the following vulnerability has been resolved: drbd: only clone bio if we...
In the Linux kernel, the following vulnerability has been resolved:
drbd: only clone bio if we have a backing device
Commit c347a787e34cb (drbd: set ->bi_bdev in drbd_req_new) moved a
bio_set_dev call (which has since been removed) to "earlier", from
drbd_request_prepare to drbd_req_new.
The problem is that this accesses device->ldev->backing_bdev, which is
not NULL-checked at this point. When we don't have an ldev (i.e. when
the DRBD device is diskless), this leads to a null pointer deref.
So, only allocate the private_bio if we actually have a disk. This is
also a small optimization, since we don't clone the bio to only to
immediately free it again in the diskless case.
Impact
The application dereferences a null pointer, causing a crash. Typical impact: denial of service via crash.
CVE-2022-50506 has a CVSS score of 5.5 (Medium). The vector is requires local access, low privileges required, and no user interaction. A CVSS score reflects the worst-case severity of the vulnerability, not your specific exposure. Whether this affects your application depends on whether the vulnerable code is present and reachable in your environment. No fixed version is listed yet, so configuration controls and monitoring matter more in the interim.
Affected versions
Security releases
Kodem intelligence
Severity tells you how bad this could be in the worst case. It does not tell you whether you are exposed. Exploitability and impact are functions of runtime truth: whether the vulnerable code is present, reachable, and actually executes in your application. A vulnerable package can sit in your dependency tree and never run.
Kodem, an Intelligent Application Security platform, uses runtime intelligence to reveal which vulnerabilities actually execute in production, so teams prioritize the ones that genuinely matter. Kodem's runtime-powered SCA identifies whether this CVE is reachable in your applications.
Already deployed Kodem?
See it in your environmentNew to Kodem? Get a demo →Remediation advice
Frequently Asked Questions
- What is CVE-2022-50506? CVE-2022-50506 is a medium-severity null pointer dereference vulnerability. No fixed version is listed yet. The application dereferences a null pointer, causing a crash.
- How severe is CVE-2022-50506? CVE-2022-50506 has a CVSS score of 5.5 (Medium). This score reflects the worst-case severity of the vulnerability, not your specific exposure. Whether it represents real risk in your environment depends on whether the vulnerable code is present and reachable.
- Is there a fix for CVE-2022-50506? No fixed version is listed for CVE-2022-50506 yet. Monitor the advisory for updates and apply mitigations in the interim.
- Is CVE-2022-50506 exploitable, and should I be worried? Whether CVE-2022-50506 is exploitable in your environment depends on whether the vulnerable code is present and reachable. A CVSS score is a worst-case rating; it does not account for your specific deployment, configuration, or usage patterns. Kodem, an Intelligent Application Security platform, uses runtime intelligence to show which vulnerabilities actually execute in production, so you can focus on the ones that represent real risk. Get a demo
- What actually determines whether CVE-2022-50506 is exploitable, and how bad it is? Exploitability and impact are not fixed properties of a CVE. They depend on runtime truth: whether the vulnerable code is present, reachable, and actually executes in your application. A high CVSS score on a dependency that never runs is not the same as real risk. Kodem, an Intelligent Application Security platform, uses runtime intelligence to reveal which vulnerabilities actually execute in production, so teams prioritize the ones that genuinely matter.